FNY Managed Accounts’s Collegium Pharmaceutical COLL Stock Holding History

FNY Managed Accounts’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2K	Buy	+113	New	+$2.69K	﹤0.01%	368

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FNY Managed Accounts's COLL Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Collegium Pharmaceutical (COLL) in Q1 2018: 113 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #368 among its holdings.

140 funds tracked by Wall St. Rank hold COLL as of Q1 2018.

FNY Managed Accounts held 113 shares of Collegium Pharmaceutical worth $2K as of Q1 2018.
Collegium Pharmaceutical was a new FNY Managed Accounts position in Q1 2018.
Collegium Pharmaceutical made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #368 holding.
140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.